claim: humanized covid-19 decoy antibody effectively blocks viral entry and prevents aces-cov-2 infection
evidence_1: proposed model for the role of the decoy antibody ace2fc in sarscov2 entry and infection the decoy antibody (ace2fc) not only reduces sarscov2 infection but also decreases tnfα secretion and adam17 phosphorylation mediated by angiotensin ii.